Lambert IH. Activation and inactivation of the volume-sensitive taurine leak pathway in NIH3T3 fibroblasts and Ehrlich Lettre ascites cells. Am J Physiol Cell Physiol 293: C390-C400, 2007; doi:10.1152/ajpcell.00104.2007.-Hypotonic exposure provokes the mobilization of arachidonic acid, production of ROS, and a transient increase in taurine release in Ehrlich Lettre cells. The taurine release is potentiated by H2O2 and the tyrosine phosphatase inhibitor vanadate and reduced by the phospholipase A 2 (PLA2) inhibitors bromoenol lactone (BEL) and manoalide, the 5-lipoxygenase (5-LO) inhibitor ETH-615139, the NADPH oxidase inhibitor diphenyl iodonium (DPI), and antioxidants. Thus, swelling-induced taurine efflux in Ehrlich Lettre cells involves Ca 2ϩ -independent (iPLA2)/secretory PLA2 (sPLA2) plus 5-LO activity and modulation by ROS. Vanadate and H2O2 stimulate arachidonic acid mobilization and vanadate potentiates ROS production in Ehrlich Lettre cells and NIH3T3 fibroblasts under hypotonic conditions. However, vanadate-induced potentiation of the volume-sensitive taurine efflux is, in both cell types, impaired in the presence of BEL and DPI and following restoration of the cell volume. Thus, potentiation of the volume-sensitive taurine efflux pathway following inhibition of tyrosine phosphatase activity reflects increased arachidonic acid mobilization and ROS production for downstream signaling. Vanadate delays the inactivation of volume-sensitive taurine efflux in NIH3T3 cells, and this delay is impaired in the presence of DPI. Vanadate has no effect on the inactivation of swelling-induced taurine efflux in Ehrlich Lettre cells.
OSMOTICALLY SWOLLEN MAMMALIAN CELLS restore their original cell volume due to net loss of ions (K ϩ /Cl Ϫ ) and organic osmolytes (taurine/nonessential amino acids) plus osmotically obliged water. The swelling-induced loss of KCl in many cell types has been shown to involve specific, volume-sensitive K ϩ and Cl Ϫ channels or the electoneutral KCl cotransporter, and it has, in the case of Ehrlich ascites tumor cells, been demonstrated that acidification shifts the preference for the volume restoring system from K ϩ /Cl Ϫ channels to the K ϩ -Cl Ϫ cotransporter (16) . The swelling-induced taurine loss is mediated by a volume-sensitive organic osmolyte anion channel, which has a well-characterized pharmacological profile and a well-defined permeability sequence for organic osmolytes (12, 22) .
Osmotic perturbation in various cell types is accompanied by marked cytoskeletal rearrangement (shift in actin polymerization), translocation of specific enzymes [phospholipase A 2 (PLA 2 ) and 5-lipoxygenase (5-LO)], mobilization of second messengers (eicosanoids and nucleotides), and shift in the balance between protein tyrosine kinase (PTK) and protein tyrosine phosphatase (PTP) activity (see Refs. 5, 22, and 38) . The initial osmo/volume sensor has not been identified yet, but in the case of NIH3T3 mouse fibroblasts, it has turned out that activation of PLA 2 is an initial upstream event in the intracellular signaling cascade, which is elicited by osmotic cell swelling and leads to activation of volume-sensitive transporters for organic and inorganic osmolytes (22) . Oxidation of arachidonic acid via the 5-LO system seems to be an additional permissive element for volume-sensitive taurine loss not only in NIH3T3 cells but also in Ehrlich ascites tumor cells, HeLa cells, C2C12 myotubes, and pig muscle (18 -20, 24, 25, 29, 35) . The PLA 2 family constists of a diverse family of enzymes that, based on functional criteria, can be divided into 1) high-molecular-weight, intracellular, Ca 2ϩ -dependent PLA 2 (cPLA 2 -␣, cPLA 2 -␤, and cPLA 2 -␥); 2) low-molecularweight, secretory, Ca 2ϩ -dependent PLA 2 (sPLA 2 ); and 3) high-molecular-weight, Ca 2ϩ -independent PLA 2 (iPLA 2 -␤ and iPLA 2 -␥) (for reviews, see Refs. 1, 7, and 47). The PLA 2 isoform(s) involved in volume-sensitive taurine release has been investigated, and it appears that the particular isoform(s) activated depends on the cell type in question, i.e., cPLA 2 -␣ distributes uniformly throughout Ehrlich ascites tumour cells under unpertubated conditions but aggregates at the nuclear area and releases arachidonic acid from the nuclear envelope within the first 2 min following hypotonic exposure (37, 42) , whereas iPLA 2 -␤ exhibits a similar role in NIH3T3 fibroblasts (39) .
ROS, e.g., the superoxide anion and its derivatives plus the lipid-permeable, nonradical oxygen species H 2 O 2 , are recognized as intracellular signaling molecules in nonphagocytic cells (10, 14, 41, 44) . Fibroblasts, in contrast to neutrophiles, produce superoxide radicals, mainly intracellularly (44) , and an increase in ROS production has been demonstrated to occur within the first minute following hypotonic exposure in NIH3T3 fibroblasts (20) , skeletal muscle (35) , and HTC cells (45) . In the case of NIH3T3 fibroblasts, it has been proposed that the swelling-induced ROS production involves NADPH oxidase (NOX) that is activated at a step downstream to iPLA 2 /sPLA 2 activation (20, 39) . Similarly, Colston and coworkers (6) demonstrated that NOX is activated downstream of cPLA 2 in cardiac fibroblasts following an exposure to exogenous H 2 O 2 .
It has been estimated that 15% cell swelling is required for activation of the taurine efflux pathway in NIH3T3 cells and that exogenous addition of H 2 O 2 potentiates the swellinginduced taurine release (20) . H 2 O 2 has no effect on taurine release from NIH3T3 cells when added under isotonic conditions, and H 2 O 2 does not affect the volume set point for activation of the efflux pathway (20) . Exposure of NIH3T3 cells to N-acetyl cysteine (NAC), which increases the intracellular level of reduced glutathione and thereby the elimination of ROS via the glutathione peroxidase system, reduces the maximal rate constant for swelling-induced taurine efflux marginally, although significantly, whereas the antioxidant butylene hydroxyl toluene (BHT) completely impairs volumesensitive taurine release in NIH 3T3 cells (20) . Furthermore, inhibition of NOX does not affect the initiation of the swellinginduced efflux pathway in NIH3T3 cells but accelerates dramatically its inactivation (20) . These observations have been taken to indicate that ROS might have dual effects in NIH3T3 cells, i.e., ROS potentiate the volume-sensitive taurine efflux pathway and delay its inactivation. Exposure of NIH3T3 cells to genistein, a general PTK inhibitor, or to PD-153035, which inhibits PTK activity coupled to EGF, reduces swelling-induced taurine efflux, whereas the addition of EGF potentiates taurine efflux following hypotonic exposure (20) . Addition of the PTP inhibitor vanadate mimics the potentiating effects of H 2 O 2 on swelling-induced taurine release and delays the inactivation of the volume-sensitve efflux pathway in NIH3T3 cells (20) . Furthermore, exogenous H 2 O 2 shifts the tyrosine phosphorylation pattern of the PTK c-Src under hypotonic conditions (23) . It has, accordingly, been suggested that the open probability of the volume-sensitive taurine release pathway in NIH3T3 cells is regulated by PTKs as well as by PTPs and that EGF receptor PTK and c-Src could be involved (23) .
The present work was initiated to 1) elucidate how ROS and PTPs are involved in the potentiation and inactivation of the volume-sensitive taurine efflux pathway and 2) test whether the effect of ROS and PTPs on volume-sensitive taurine release is cell type dependent. Using NIH3T3 fibroblasts and Ehrlich Lettre cells, an adherent version of Ehrlich ascites tumor cells, we show that 1) multiple PLA 2 isoforms, 5-LO, and NOX are involved in the activation of volume-sensitive taurine release in both cell types; 2) inhibition of PTP activity increases arachidonic acid release and ROS production and potentiates the swelling-induced taurine efflux in both cell types; and 3) inhibition of PTPs delays the inactivation of the volumesensitive efflux pathway in NIH3T3 cells, whereas the inactivation in Ehrlich Lettre cells is unaffected. Inhibition of NOX leads to a rapid inactivation of the volume-sensitive taurine efflux pathway even in the presence of a PTP inhibitor. It is suggested that increased tyrosine phosphorylation of regulatory components of NOX leads to increased ROS production and a subsequent delay in the inactivation of the volume-sensitive taurine efflux pathway and that the expression and activity of NOX or the antioxidative capacity differ between NIH3T3 cells and Ehrlich Lettre cells.
MATERIALS AND METHODS
Chemicals. Antibiotics (penicillin and streptomycin), DMEM (GIBCO; high glucose and L-glutamine), FCS (GIBCO), and trypsin (10ϫ, GIBCO) were from Invitrogen. RPMI-1640 (L-glutamine) was from Sigma Chemical (St. Louis, MO). [ 3 H]taurine and arachidonic acid were from Amersham. 5-(and 6-)carboxy-2Ј,7Ј-dichlorodihydrofluorescein diacetate (carboxy-H 2DCFDA) was from Molecular Probes (Leiden, The Netherlands). ETH-615139 was donated by Dr. I. Ahnfeldt-Rønne (Løven Kemiske Fabrik). All other compounds were from Sigma-Aldrich. The following stock solutions were prepared: vanadate (Na 3VO4, 20 mM, solvent H2O), H2O2 (1 M, solvent water), BHT (400 mM, solvent H 2O), bromoenol lactone (BEL; 10 mM, solvent DMSO), manoalide (1 mM, solvent ethanol), diphenylene iodonium (DPI; 10 mM, solvent ethanol), ETH-615139 (2 mM, solvent ethanol), and carboxy-H 2DCFDA (50 mM, solvent DMSO).
Inorganic media. PBS contained (in mM) 137 NaCl, 2.6 KCl, 6.5 Na 2HPO4, and 1.5 KH2PO4. Isosmotic NaCl medium (300 mosM) contained (in mM) 143 NaCl, 5 KCl, 1 Na 2HPO4, 1 CaCl2, 0.1 MgSO 4, and 10 HEPES. Isoosmotic, Na ϩ -free, N-methyl-D-glucamine (NMDG)-Cl medium was prepared as the isotonic NaCl medium with NMDG-Cl being substituted for NaCl in equimolar amounts. Hypoosmotic NaCl/NMDG media (200 mosM) were obtained by reduction of NaCl/NMDG in isoosmotic solutions to 95 mM, with the other components remaining unchanged. pH was adjusted at 7.40 in all solutions.
Cell cultures. NIH3T3 mouse fibroblasts (clone 7) and Ehrlich Lettre ascites cells (American Type Culture Collection) were grown in 75-cm 2 culture flasks as monolayer cultures in DMEM and RPMI-1640, respectively, containing heat-inactivated FBS (10%) and antibiotics. Both cells lines were kept at 37°C/5% CO2/100% humidity and split every 3-4 days using 0.5% trypsin in PBS to detach the cells.
Estimation of ROS production. Cells were cultured for 24 h in serum containing growth media on HCl-and ethanol-washed glass coverslips (10 -50 mm). Confluence at the time of ROS estimation was 80%. For the estimation of ROS, cells were washed two times with PBS and subsequently incubated in serum-free growth medium containing the ROS-sensitive fluorescent probe carboxy-H2DCFDA (20 M, 2 h). Cells were subsequently washed with isotonic solution, and coverslips were placed vertically in a polystyrene cuvette (10-mm path length, 50°angle relative to the excitation light) containing experimental solution. ROS estimation was performed on a PTI Ratio Master spectrophotometer, and the experimental solution in the cuvette was continuously stirred by use of a Teflon-coated magnet driven by a motor attached below the cuvette house. Excitation and emission wavelengths were 490 and 515 nm, respectively, and data were collected every 2 s for 400 s. As the ROS-dependent fluorescence depends on cell density, dye concentration and incubation time were estimated as the effect of reduction in osmolarity and addition of diverse agents by comparing time traces obtained from the same cell preparation.
Estimation of cell volume. Cells, grown to ϳ80% confluence in 175-cm 2 culture flasks, were detached by trypsination (0.2% trypsin in PBS) at 37°C. Trypsination was terminated by the addition of 10 ml of growth medium, and the suspension was transferred to a Sorwal glass (50 ml), centrifuged gently (4 min, 700 g), and resuspended in 5 ml of isotonic Na ϩ -free NMDG-Cl medium. Three milliliters of the resuspended cells were diluted 20 times in hypotonic NMDG-Cl medium, and the cell volume was estimated by electronic cell sizing in a Coulter counter. All media were filtered (0.45-m filters). Absolute cell volumes (fluid Ϸ 10 Ϫ15 liters) were obtained from the median of the distribution curves after calibration with latex beads (14.25 m diameter, Coulter Electronics).
Estimation of the rate constant for taurine efflux and fractional arachidonic acid release. Efflux measurements were performed as described previously (15, 20, 39) . Briefly, taurine efflux was estimated at room temperature on NIH3T3/Ehrlich Lettre cells grown to 80% confluence in six-well polyethylene dishes (9.6 cm 2 /well) and loaded with 1 ml of growth media containing [ 3 H]taurine (2 Ci/well, 2 h). Cells were washed four times with isosmotic media to remove excess extracellular [ 3 H]taurine and cellular debris. Efflux was initiated by aspiration of the medium followed by the addition of 1 ml of experimental solution. Cells were left for 2 min, whereafter the entire medium was transferred to a scintillation vial and rapidly substituted by 1 ml of fresh medium. This procedure was repeated for 20 -30 min. At the end of the experiment, cells were lysed by the addition of 1 ml NaOH (0.5 mM, 1 h). The total pool of labeled taurine in the cell system was estimated as the sum of 3 H activity (␤-scintillation counting, Ultima Gold) in all the efflux samples (the NaOH lysate plus two final well washouts with double-distilled H 2O). Release of taurine under the present experimental conditions follows a monoexponential equation, and the natural logarithm to the fraction of [ 3 H]taurine remaining in the cells at a given time was plotted versus time. The rate constant (k; in min Ϫ1 ) for the taurine efflux at each time point was subsequently estimated as the negative slope of the graph between the time point and the proceeding time point. Inactivation of swellinginduced taurine efflux at time t following hypotonic exposure (%) was estimated as follows: 100 ϫ (k t Ϫ kinit)/(kmax Ϫ kinit), where kt, kinit, and kmax are the rate constants estimated under hypotonic conditions at time t, under isotonic conditions prior to hypotonic exposure, and under hypotonic conditions at maximal activation, respectively. Arachidonic acid release was estimated using a similar protocol as the one used for estimation of taurine efflux with the exception that cells were loaded with [ 3 H]arachidonic acid (3 Ci/well, 24 h), 1% BSA was added to the efflux medium to trap released arachidonic acid, and an additional washout was performed with methanol. 
RESULTS
It has previously been demonstrated that release of taurine from NIH3T3 cells is transiently increased following hypotonic exposure and that the addition of ROS or inhibition of PTPs potentiate swelling-induced taurine release (20) . These observations are confirmed by the results shown in Fig. 1 , where the addition of the PTP inhibitor vanadate (50 M) and H 2 O 2 in the range 0.1-2 mM potentiated the maximal rate constant for volume-sensitive taurine efflux in NIH3T3 cells ( tonic exposure (Fig. 1B) and that the maximal rate constant for the volume-sensitive taurine efflux was significantly potentiated in the presence of vanadate (50 M) and H 2 O 2 in the range of 0.1-2 mM (Fig. 1C) . Inclusion of 0.5 mM of the water-soluble antioxidant BHT in the hypotonic medium reduced the maximal rate constant for volume-sensitive taurine efflux in Ehrlich Lettre cells to 1.0 Ϯ 0.3% of the control value (4 sets of paired experiments). Thus, exposure to ROS and inhibition of PTP activity potentiates the swelling-induced release of taurine release from Ehrlich Lettre cells as well as NIH3T3 cells. Figure 1D shows inactivation of the volume-sensitive taurine efflux pathway following hypotonic exposure was delayed in the presence of H 2 O 2 in both cell types, i.e., inactivation was reduced compared with control cells but still increased with time (compare inactivation at 20 and 24 min). However, inactivation of the volume-sensitive taurine efflux pathway was significantly delayed by vanadate in NIH3T3 cells (Fig. 1, A  and D) , whereas inactivation of the efflux pathway was almost unaffected by vanadate in Ehrlich Lettre cells (Fig. 1, B and D) , i.e., inactivation of the volume-sensitive taurine efflux pathway after 14 min of hypotonic exposure (time: 20 min) was reduced by vanadate from ϳ50% to 10% in NIH3T3 cells, whereas inactivation was even slightly increased by vanadate from ϳ60% and 70% in Ehrlich Lettre cells (Fig. 1D ). Thus, ROS (H 2 O 2 ) delayed inactivation of the volume-sensitive taurine efflux pathway in NIH3T3 cells as well as in Ehrlich Lettre cells, whereas inhibition of PTPs delayed inactivation of the efflux pathway in NIH3T3 fibroblasts but apparently had no effect on the inactivation of the efflux pathway in Ehrlich Lettre cells.
It has previously been demonstrated that the release of arachidonic acid from the nuclear envelope is increased in NIH3T3 cells following hypotonic exposure, although no concomitant release to the extracellular compartment was detected (39) . Figure 2 shows that in contrast to NIH3T3 cells (Fig. 2,  A and C) , a small but significant increase in the release of arachidonic acid to the extracellular space was demonstrated in Ehrlich Lettre cells following hypotonic cell swelling (Fig. 2 , B and D). Exposure to 1 mM H 2 O 2 stimulated arachidonic acid release under isotonic as well as hypotonic conditions in both cell types (Fig. 2, C and D) . Furthermore, arachidonic acid release was significantly increased by vanadate under hypotonic conditions, although the release seemed to be quantitatively larger in NIH3T3 cells compared with Ehrlich Lettre cells (Fig. 2, C and D) . The swelling-induced release of arachidonic acid and taurine in NIH3T3 cells involves manoalide-sensitive sPLA 2 activity and BEL-sensitive iPLA 2 activity (27, 39) , and the experiments shown in Fig. 3 were initiated to characterize the PLA 2 isoforms involved in swelling-induced taurine efflux in Ehrlich Lettre cells and to test whether the vanadate-induced potentiation of swelling-induced taurine efflux shown in Fig. 1 reflected the vanadate-induced increase in arachidonic acid release, i.e., increased availability of lipid substrate for downstream signaling. Figure 3A shows that manoalide as well as BEL significantly reduced the maximal rate constant for volume-sensitive taurine efflux in Ehrlich Lettre cells. Furthermore, addition of the 5-LO inhibitor ETH-615139 also reduced the maximal rate constant for swellinginduced taurine release in Ehrlich Lettre cells (Fig. 3A) . Thus, sPLA 2 Figure 3 also shows that BEL reduced the maximal rate constant for volume-sensitive taurine efflux in vanadate-treated Ehrlich Lettre cells (Fig. 3A) and vanadate-treated NIH3T3 cells (Fig. 3B) . Hence, the potentiation of volume-sensitive taurine efflux following inhibition of PTPs requires BEL-sensitive PLA 2 activity, i.e., the potentiation could be secondary to the concomitant increase in arachidonic acid release. Figure 4 shows that ROS production was significantly increased in NIH3T3 cells (Fig. 4, A and C) as well as in Ehrlich Lettre cells (Fig. 4, B and D) following hypotonic exposure. Furthermore, exposure to vanadate stimulated ROS production in both cell types under isotonic conditions (Fig. 4, A and C) as well as hypotonic conditions (Fig. 4, B and D) . Thus, the potentiating effect of vanadate on swelling-induced taurine efflux demonstrated in Fig. 1 could be secondary to an increased arachidonic acid release (Fig. 3) and/or increased ROS production (Fig. 4) . Multicomponent NOX has been assigned a role in swelling-induced taurine release in NIH3T3 cells (20) and HeLa cells (45) , and, as shown in Fig. 5 , addition of the NOX inhibitor DPI reduced the maximal rate constant for swelling-induced taurine efflux significantly in Ehrlich Lettre cells (Fig. 5A) , whereas DPI had no inhibitory effect on the maximal rate constant for swelling-induced taurine efflux in NIH3T3 cells (Fig. 5B) . However, DPI exposure reduced the maximal rate constant significantly under hypotonic conditions in the presence of vanadate in both cell types (Fig. 5, A and B) . Thus, the potentiation of volume-sensitive taurine efflux in NIH3T3 and Ehrlich Lettre cells following inhibition of PTPs could well reflect the concomitant increase in arachidonic acid release and ROS production via the NOX system.
The experiments shown in Figs. 6 -8 were performed to investigate the vanadate-induced delay of inactivation of the volume-sensitive taurine efflux pathway in NIH3T3 cells (Fig.  1 ). In agreement with previous published data (20), exposure to vanadate or H 2 O 2 did not elicit taurine release under isotonic conditions in NIH3T3 cells (Fig. 1) . The question is whether the volume-sensitive taurine efflux in vanadate-and H 2 O 2 -exposed NIH3T3 and Ehrlich Lettre cells remains high if the cell volume is reduced toward its original value. A shift from hypotonic to isotonic conditions will inevitably return the cell volume to or below the original value. Alternatively, as the K ϩ conductance is often rate limiting the regulatory volume decrease following hypotonic exposure, addition of the cation ionophore gramicidin under hypotonic, Na ϩ -free conditions will inevitably accelerate the volume-restoring process. Figure  6 shows that gramicidin accelerated the volume restoration in NIH3T3 cells (open bars) and Ehrlich Lettre cells (filled bars) following cell swelling in Na ϩ -free, NMDG-Cl medium in the absence as well as in the presence of vanadate. Thus, the K ϩ conductance is rate limiting the regulatory volume recovery in both cell types not only under hypotonic, vanadate-free control conditions but also following inhibition of PTPs by vanadate. Note that the addition of vanadate to the hypotonic medium had, in itself, a minor accelerating effect on the volumerestoring process in NIH3T3 cells following hypotonic exposure (Fig. 6) . Figure 7A shows that the rate constant for taurine release from NIH3T3 cells even in the presence of H 2 O 2 returned to its isotonic value within 6 min following substitution of isotonic medium for hypotonic medium. It is estimated that the inactivation of the taurine pathway following the 6-min reintroduction of isotonic conditions was increased from 70% 
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REGULATION OF VOLUME-SENSITIVE TAURINE RELEASE to 100% in the absence of modulators (Fig. 7C, open bars) , from ϳ10% to 90% in the presence of H 2 O 2 (Fig. 7C , light gray bars), and from ϳ40% to 90% in the presence of vanadate (Fig. 7C, dark gray bars) . As shown Fig. 7B , swelling-induced taurine release from NIH3T3 cells was also reduced in the presence of vanadate under hypotonic, Na ϩ conditions following the addition of gramicidin, i.e., inactivation of the taurine pathway in NIH3T3 cells was in the presence of vanadate estimated to increase from 35% to 100% and from 35% to 70% within 8 min following the substitution of isotonic solution for the hypotonic solution or substitution of the hypotonic gramicidin-containing solution for the hypotonic solution, respectively (Fig. 7D ). In the case of Ehrlich Lettre cells, restoration of the original cell volume following exposure to the hypotonic, Na ϩ -free, vanadate-containing medium had no greater effect on the inactivation of the volume-sensitive taurine efflux pathway (Fig. 7D) , most probably because the inactivation of the efflux pathway in the presence of vanadate was already significant and close to the control values in nontreated cells (Fig. 7D) . Taken together, the lack of an effect of H 2 O 2 and vanadate on taurine release under isotonic conditions and following restoration of the cell volume indicates that inhibition of PTP activity in NIH3T3 cells modulates the activity of the volume-sensitive efflux pathway for taurine once it is activated and not the activation per se.
As shown in Fig. 3 , the increase in the ROS production in NIH3T3 cells was significantly potentiated by vanadate under hypotonic conditions. To test whether the delayed inactivation of the swelling-induced taurine efflux pathway in vanadatetreated NIH3T3 cells was secondary to the increased ROS production, taurine efflux was followed in vanadate-treated cells in the absence and presence of the NOX inhibitor DPI. As shown in the time trace in Fig. 8A , the effect of vanadate on the volume-sensitive taurine efflux in NIH3T3 cells was completely lifted in the presence of DPI. It is estimated that exposure to DPI increased inactivation of the volume-sensitive taurine efflux pathway in NIH3T3 cells following 18 min of hypotonic exposure from 40% to 100% and from 10% to 100% in the absence and presence of vanadate, respectively (Fig.  8C ). In the case of Ehrlich Lettre cells, DPI reduced the maximal rate constant for the swelling-induced taurine efflux significantly (see Fig. 5 ), and the volume-sensitive taurine efflux pathway inactivated almost completely (Fig. 8B) . It is estimated that DPI increased the inactivation in Ehrlich Lettre cells of the volume-sensitive taurine efflux pathway following 18 min of hypotonic exposure from 70% to 90% and from 80% to 90% in the absence and presence of vanadate, respectively (Fig. 8D) . Thus, the delayed inactivation of the swellinginduced taurine efflux in NIH3T3 cells following the inhibition of PTP activity most probably reflects the effect of increased ROS production via the NOX system.
DISCUSSION
PLA 2 and swelling-induced activation of taurine efflux. Taurine plays an important role as an organic osmolyte in mammalian cells, but taurine is also involved in various physiological processes, i.e., taurine affects membrane properties (architecture and fluidity), modulates the binding affinity and capacity of Ca 2ϩ to phospholipids, and acts as an antioxidant due to its conversion of hypochlorous acid to the less-toxic compound taurine-chloramine (3, 22) . Thus, shift in the cellular taurine pool in connection with cell volume adjustment will inevitably have an impact on cell function. Taurine is accumulated in mammalian cells via the high-affinity taurine transporter TauT (22, 46) and released via a volume-sensitive taurine efflux pathway that is sensitive to pH, the prevailing membrane potential, and modulated by ROS, PTPs and PTKs (22) . The mechanisms involved in the activation of the volume-sensitive taurine efflux pathway are diverse and highly cell type dependent. Inhibitors of PLA 2 and 5-LO reduce taurine release from hypotonic-swollen Ehrlich ascites tumor cells (25) , HeLa cells (29) , NIH3T3 cells (21, 39) , and adherent Ehrlich Lettre cells (Fig. 3) . This is taken to indicate that activation of the volume-sensitive taurine efflux pathway is downstream from PLA 2 -mediated mobilization of arachidonic and oxidation of arachidonic acid by 5-LO. Using a pharmacological approach, it has turned out that the swelling-induced taurine release in the adherent NIH3T3 and Ehrlich Lettre cells involves iPLA 2 as well as sPLA 2 (20, 39) (Fig. 3A) . 5-LO is known to localize at the nuclear membrane (31) , and a marked nuclear localization of iPLA 2 (subtype iPLA 2 -VIA) and mobilization of arachidonic acid from the nuclear envelope occurs in NIH3T3 cells within minutes following hypotonic exposure (39) . Furthermore, even though arachidonic acid release to the extracellular compartment is not detectable in NIH3T3 cells under normal hypotonic conditions (28, 39) (Fig. 2C) , it is actually increased in the presence of a 5-LO inhibitor (28) , indicating that PLA 2 activity is increased at the nuclear envelope in NIH3T3 cells following cell swelling and that the arachidonic acid mobilization is most probably masked by a rapid oxidization via the 5-LO system. Increased PLA 2 aggregation (cPLA 2 -␣) at the nuclear envelope within the first minutes following hypotonic exposure and a concomitant mobilization of arachidonic acid and oxidation of arachidonic acid to leukotrienes via the 5-LO system have similarly been demonstrated in Ehrlich ascites tumor cells (26, 37) . Activation of iPLA 2 isoforms has been previously reported to involve ROS (17, 32), and it seems plausible that ROS via peroxidation of lipids, shift in membrane fluidity, or oxidative modification of proteins could affect iPLA 2 activity and thus account for the swelling-induced release of arachidonic acid from the nuclear envelope and the concomitant release of taurine in NIH3T3 cells. However, the swelling-induced ROS production in NIH3T3 cells is impaired in the presence of BEL (20) , indicating that stimulation of ROS-producing enzymes is downstream from PLA 2 activation. It is noted that the addition of vanadate under isotonic conditions increases ROS production (Fig. 4) , which, according to the results shown in Fig. 2 , should elicit an increase in arachidonic acid mobilization. However, no detectable effect on arachidonic acid mobilization (Fig. 2) or taurine release (Fig. 1) was seen in vanadate-treated cells under isotonic conditions, presumably because the ROS production following vanadate exposure was quantitatively insufficient to activate PLA 2 .
NOX and swelling-induced ROS production. Phagocyte NOX is acknowledged for its role in host defense, whereas NOX in nonphagocytes has been assigned a role in intracellular cell signaling (30) and cell volume restoration (20, 45) . The NOX system comprises catalytic, membrane-integrated gp91 phox homologs (NOX1, NOX3, NOX4, NOX5, DUOX1, and DUOX2) plus the regulatory units Rac1/2, p22 phox , p47 phox (NOXO1), p40 phox , and p67 phox (NOXA1) (30, 40) . Osmotic cell swelling is accompanied by increased ROS production in, e.g., NIH3T3 cells (20) (Fig. 4) , pig skeletal muscle cells (35) , HTC cells (45) , and Ehrlich Lettre cells (Fig. 4) . PLA 2 products, e.g., arachidonic acid and lysophosphatidyl choline, in themselves increase ROS production (22) , and, as the swelling-induced ROS production in NIH3T3 cells is impaired in the presence of the NOX inhibitor DPI (M. B. Friis, K. G. Vorum, and I. H. Lambert, unpublished data), it is conceivable that NOX contributes to the swelling- Fig. 7 . Effect of vanadate and H2O2 on volume-sensitive taurine efflux in NIH3T3 and Ehrlich Letre cells following restoration of cell volume. Taurine efflux was initiated, and the rate constant for taurine efflux and inactivation of the volume-sensitive taurine efflux pathway was estimated as in Fig. 1 . A: taurine efflux was followed in NIH3T3 cells in NaCl media in the presence of 1 mM H2O2. Medium was shifted from isotonicity to hypotonicity at the time indicated by the first arrow and either remained hypotonic (■) or shifted to isotonicity (F) at the time indicated by the second arrow. B: taurine efflux was followed in NIH3T3 cells in Na ϩ -free, NMDG-Cl media in the presence of 50 M vanadate. Medium was shifted from isotonicity to hypotonicity at the time indicated by the first arrow and either remained hypotonic (■) or was substituted by hypotonic medium containing 2 M gramicidin (F) at the time indicated by the second arrow. C: taurine release from NIH3T3 cells was estimated in NaCl media in the absence (control) or presence of 1 mM H2O2 or 50 M vanadate according to the protocol in A, i.e., isotonic NaCl medium was at time ϭ 4 min shifted to hypotonic NaCl medium and the hypotonic medium was at time ϭ 18 min either kept hypotonic or shifted to isotonic NaCl medium (hypotonic 3 isotonic). Inactivation was estimated at time ϭ 24 min. D: taurine release from NIH3T3 and Ehrlich Lettre cells was estimated in Na ϩ -free NMDG-Cl media in the absence (control) or presence of 50 M vanadate according to the protocol in B, i.e., isotonic NMDG-Cl medium was at time ϭ 6 min shifted to hypotonic NMDG-Cl medium and the hypotonic medium was at time ϭ 16 min either kept hypotonic or shifted to hypotonic NMDG-Cl medium containing 2 M gramicidin (Hypo 3 Hypo ϩ Gram) or to isotonic NMDG-Cl medium (Hypo 3 Iso). Inactivation was estimated at time ϭ 24 min. All values are given as mean values Ϯ SE. Time traces are representative of 4 (A) and 3 (B) sets of experiments. Inactivation was estimated from 4 (C) and 3 (D) sets of experiments. #Significantly reduced compared with hypotonic control; *significantly increased compared with hypotonic control cells exposed to vanadate.
induced ROS production in NIH3T3 cells. It is noted that DPI interferes with at least two components of the NOX complex that differ by their sensitivity to the inhibitor (8), i.e., the negligible versus pronounced effect of DPI on the maximal rate constant for the swelling-induced taurine efflux in control NIH3T3 cells (Fig. 5B ) and control Ehrlich Lettre cells (Fig.  5A ) could reflect variation in the expression of regulatory and catalytic components of NOX in the two cell types.
Several PTKs are involved in the regulation of the cellular pool of organic osmolytes in mammalian cells (see Ref. 36) , and it has been demonstrated that the swelling-induced taurine efflux as well as the potentiating effect of H 2 O 2 and vanadate on the swelling-induced taurine efflux in NIH3T3 are strongly impaired in the presence of the general protein kinase inhibitor genistein (20) . Furthermore, nonreceptor PTK c-Src has been shown to stimulate NOX-driven generation of ROS in a process that involves tyrosine phosphorylation and subsequent translocation of the regulatory unit p47 phox (4, 43) . It is thus conceivable that increased net tyrosine phosphorylation and activation of p47 phox could explain the increased ROS production in vanadate-exposed cells (Fig. 4) .
The volume-sensitive taurine efflux is potentiated following exposure to Ca 2ϩ -mobilizing agonists (20, 29) and the PKCactivating agent PMA (21) . It has been shown that the Ca 2ϩ -induced potentiation in the case of HeLa cells involves calmodulin and PKC (novel PKC) activity (9), whereas PMAinduced potentiation in the case of NIH3T3 cells involves NOX (21) . NOX activity is regulated by Ca 2ϩ (2) and by phosphorylation of p47 phox by classic/novel, Ca 2ϩ -sensitive PKCs (11) . Furthermore, exposure to vanadate under hypotonic conditions elicits an instantaneous increase in the cellular Ca 2ϩ concentration in NIH3T3 and Ehrlich Lettre cells (fura2 estimation; M. B. Friis, K. G. Vorum, and I. H. Lambert, unpublished data) as well as an increase in ROS production (Fig. 4) . It is currently under investigation whether the effect of vanadate on the swelling-induced taurine release reflects increased NOX activity provoked by Ca 2ϩ mobilization or a shift in the net tyrosine phosphorylation of the p47 phox (NOXO1) unit.
ROS potentiate volume-sensitive taurine efflux. Several lines of evidence have indicated that ROS are not involved in the activation of the volume-sensitive taurine efflux pathway per se but modulate volume-sensitive taurine efflux once it has been activated: 1) H 2 O 2 does not induce taurine efflux under isotonic conditions but potentiates taurine release under conditions where PLA 2 activity is ensured by either osmotic cell swelling or exposure to melittin (20, 27, 39); 2) H 2 O 2 does not affect the volume set point for the efflux pathway, i.e., the degree of cell swelling required for the activation of volumesensitive taurine efflux (20) ; 3) the volume-sensitive taurine efflux pathway is inactivated following restoration of cell volume even in the presence of H 2 O 2 and vanadate (Fig. 7) ; 4) H 2 O 2 has no effect on swelling-induced taurine release in the presence of a 5-LO inhibitor (20) ; 5) exposure to the antioxidant BHT or NAC reduces swelling-induced taurine efflux (20) ; and 6) exposure to the NOX inhibitor DPI accelerates the inactivation of volume-sensitive taurine efflux (20) (Fig. 8) . H 2 O 2 and the phosphate analog vanadate are assumed to reduce cellular PTP (subtype PTP1B) activity via oxidation of a cystein hydroxyl group in the catalytic site of the phosphate or by competitive inhibition, respectively (13, 33) . As shown in Figs. 3 and 5, the iPLA 2 inhibitor BEL and the NOX inhibitor DPI significantly reduced the swelling-induced taurine efflux in vanadate-treated NIH3T3 and Ehrlich Lettre cells. Thus, it is conceivable that the potentiation of the rate constant for the volume-sensitive taurine efflux following inhibition of PTP activity reflects a concomitant increase in the activity of BEL-sensitive iPLA 2 (arachidonic acid mobilization), NOX (ROS production), and/or the 5-LO system (production of second messengers for downstream signaling). In this context, it is noted that ROS are reported to stimulate iPLA 2 isoforms (17, 32) and NOX (45) , and they are required for the activation of the 5-LO system (34) . Thus, swellinginduced ROS production could stimulate 5-LO activity and, at the same time, constitute a positive feedback loop.
ROS delay inactivation of the volume-sensitive taurine efflux pathway. Exposure to ROS delays the inactivation of the volume-sensitive taurine efflux pathway in NIH3T3 cells and, to a minor extent, in Ehrlich Lettre cells (Fig. 1D) . On the other hand, vanadate-induced inhibition of PTPs delays the inactivation of volume-sensitive taurine efflux in NIH3T3 cells significantly, whereas it has no or even a stimulating effect on the inactivation of the efflux pathway in Ehrlich Lettre cells (Fig. 1) . Volume-sensitive efflux pathways for K ϩ and Cl Ϫ and thus the general volume-restoring process following hypotonic exposure are also modulated by PTKs and PTPs (see Ref. 36) , and, as taurine release increases with cell volume (20) , the vanadate-induced delay in the inactivation of the volumesensitive taurine efflux pathway in NIH3T3 cells could reflect impaired volume restoration. As shown in Fig. 7 , the volumesensitive taurine efflux pathway is inactivated when the original cell volume is restored either by reexposure to isotonic medium or by exposure to gramicidin under hypotonic, Na ϩ -free conditions. As vanadate has a minor accelerating effect on volume restoration following hypotonic cell swelling in both cell lines (Fig. 6) , it seems reasonable to assume that the vanadate-induced delay of the inactivation of the volumesensitive taurine efflux pathway in NIH3T3 cells reflects an increased tyrosine phosphorylation of components that modulate the open probability of the volume-sensitive taurine efflux pathway and not an indirect effect due to inhibition of K ϩ and Cl Ϫ conductance and thus the overall ability to restore the cell volume. However, the vanadate-induced delay of the inactivation of the swelling-induced taurine efflux pathway in NIH3T3 cells was completely abolished in the presence of DPI (Fig. 8) . The PTP inhibitor pervanadate has previously been shown to activate NOX via a tyrosine kinase-dependent pathway (48) . Hence, an increase in the net tyrosine phosphorylation of a regulatory component of NOX and a concomitant increase in the oxidase activity (Fig. 4) could explain the vanadate-induced impairment of the inactivation of the volume-sensitive taurine efflux pathway in NIH3T3 cells. Whether the open probability of the yet-unidentified taurine efflux pathway is directly increased by ROS-mediated oxidation or an increase in the net tyrosine phosphorylation is unknown. We are currently investigating whether the difference in the inactivation of the volume-sensitive taurine pathway in vanadate-treated NIH3T3 and Ehrlich Lettre cells can be explained by differences in either the expression of regulatory components and thus the activity of multicomponent NOX or an antioxidative capacity in the two cell lines.
In conclusion, inhibition of PTP activity in NIH3T3 and Ehrlich Lettre cells, i.e., a putative increase in the net tyrosine phosphorylation of various proteins/enzymes, increases arachidonic acid mobilization, stimulates ROS production, and potentiates taurine efflux under hypotonic conditions. PTP inhibition impairs the inactivation of the volume-sensitive taurine efflux pathway in NIH3T3 cells but has no effect on the inactivation of the efflux pathway in Ehrlich Lettre cells. However, the potentiation of swelling-induced taurine release is impaired and inactivation of the volume-sensitive taurine efflux pathway is accelerated dramatically following inhibition of NOX. It is suggested that 1) increased tyrosine phosphorylation of regulatory components of NOX leads to increased ROS production and subsequent potentiation of the swellinginduced taurine efflux and a delay in the inactivation of the volume-sensitive taurine efflux pathway, and 2) the opposing effect of PTP inhibition on inactivation of the volume-sensitive taurine efflux pathway in NIH3T3 and Ehrlich Lettre cells could reflect differences in the expression/activity of NOX or the antioxidative capacity.
